LAWRENCE J LEADER

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease HATTIESBURG, MS NPI 1508970211

General Payments — all program years on this page

$40,414.80

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 136
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $377.49 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $377.4920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $227.667
2019 $8,763.2728
2020 $11,521.7317
2021 $11,931.5024
2022 $7,281.1222
2023 $312.0318
2024 $377.4920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078064888 Janssen Pharmaceuticals, Inc $20.34 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078065028 Janssen Pharmaceuticals, Inc $20.34 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078065048 Janssen Pharmaceuticals, Inc $16.62 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088938 Novartis Pharmaceuticals Corporation $12.05 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088940 Novartis Pharmaceuticals Corporation $14.73 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088942 Novartis Pharmaceuticals Corporation $11.18 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088948 Novartis Pharmaceuticals Corporation $6.00 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088950 Novartis Pharmaceuticals Corporation $16.19 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088954 Novartis Pharmaceuticals Corporation $16.47 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088960 Novartis Pharmaceuticals Corporation $17.54 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088962 Novartis Pharmaceuticals Corporation $16.22 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088966 Novartis Pharmaceuticals Corporation $15.51 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088968 Novartis Pharmaceuticals Corporation $16.02 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087088972 Novartis Pharmaceuticals Corporation $11.41 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104147828 ABBVIE INC. $14.08 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039600 Boehringer Ingelheim Pharmaceuticals, Inc. $13.73 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039602 Boehringer Ingelheim Pharmaceuticals, Inc. $65.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142298993 ABIOMED $28.93 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142299089 ABIOMED $23.38 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142299091 ABIOMED $20.97 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.